Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Benzenesulfonate amlodipine dispersible tablet and preparation method thereof

A kind of technology of amlodipine besylate and ammonia chloride sulfonate, applied in the field of amlodipine besylate dispersible tablet and preparation thereof, can solve the problems of low dissolution rate, poor stability and the like, and achieve high dissolution rate and good stability , the effect of controlling blood pressure

Inactive Publication Date: 2019-01-01
南通久和药业有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem to be solved in the present invention is to overcome the poor stability of the amlodipine besylate dispersible tablet in the prior art, and the defect that the dissolution rate is low, provide a kind of amlodipine besylate dispersible tablet with high dissolution rate and preparation method thereof

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzenesulfonate amlodipine dispersible tablet and preparation method thereof
  • Benzenesulfonate amlodipine dispersible tablet and preparation method thereof
  • Benzenesulfonate amlodipine dispersible tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023]

[0024] Mix amlodipine besylate, carboxymethyl starch sodium and 1 / 3 microcrystalline cellulose according to the prescription amount for 8 minutes, and pass through a 40-mesh sieve. Add the remaining amount of microcrystalline cellulose and mix for 15 minutes; then add the prescribed amount of anhydrous calcium phosphate and mix for 25 minutes, and finally mix with magnesium stearate for 5 minutes, and compress into tablets.

Embodiment 2

[0026]

[0027] Amlodipine besylate, sodium starch glycolate and 1 / 3 microcrystalline cellulose according to the prescription amount were mixed for 10 minutes and passed through a 40-mesh sieve. Add the remaining amount of microcrystalline cellulose and mix for 10 minutes; then add the prescribed amount of anhydrous calcium phosphate and mix for 20 minutes, and finally mix with magnesium stearate for 3 minutes, and press into tablets.

Embodiment 3

[0029]

[0030] Embodiment 1~3 compares (n=6, X ± SD) to commercially available common tablet amlodipine dissolution rate

[0031]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a benzenesulfonate amlodipine dispersible tablet, which is prepared from the following ingredients in percentage by mass: 3.5% of benzenesulfonate amlodipine, 42-82% of microcrystalline cellulose SH102, 12.5-45% of dicalcium phosphate anhydrous, 1.0-6.0% of carboxymethyl starch sodium and 1.0-3.0% of magnesium stearate. The preparation method comprises the following steps:firstly, adding benzenesulfonate amlodipine, carboxymethyl starch sodium and 1 / 3 of microcrystalline cellulose of a prescription dosage to be mixed for 8-15 minutes, sieving by a sieve of 40 meshes, and adding a residual quantity of microcrystalline cellulose to be mixed for 8-15 minutes; then, adding the dicalcium phosphate anhydrous of the prescription dosage to be mixed for 15-25 minutes, finally, mixing with magnesium stearate for 2-5 minutes, and tableting. The benzenesulfonate amlodipine dispersible tablet provided by the invention has the advantages of the tablet and liquid preparation,is convenient in taking, is quick in disintegration, is quick in absorption and higher in blood pressure reduction effect and is high in bioavailability, blood pressure is more effectively controlled, and the adverse reaction of the medicine can be lowered. A 5-min dissolution rate is as high as 97.8%, and therefore, the benzenesulfonate amlodipine dispersible tablet has the advantages of high accumulated dissolution rate, high bioavailability, good stability, simple preparation technology and the like and is suitable for industrialized production and the like.

Description

technical field [0001] The invention relates to amlodipine besylate dispersible tablets and a preparation method thereof. Background technique [0002] Amlodipine besylate is the third-generation long-acting dihydropyridine calcium channel antagonist, which mainly inhibits the calcium storage capacity of myocardial and vascular smooth muscle cell membranes and the ability to combine with calcium ions, allowing extracellular calcium ions to enter through slow channels. The reduction of flow muscle cells directly relaxes vascular smooth muscle, expands vascular arterioles, reduces peripheral resistance, and achieves the effect of lowering blood pressure. It has long half-life, high bioavailability, mild, slow and long-lasting action, few side effects, remarkable curative effect, easy to use, does not affect blood lipid and blood sugar metabolism, and has no damage to liver and kidney functions. [0003] Amlodipine besylate has poor stability to humidity, heat and light, and i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K47/36A61K31/4422A61P9/12
CPCA61K9/2059A61K31/4422A61P9/12
Inventor 顾广才马泽文
Owner 南通久和药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products